High-dose high-frequency aflibercept for recalcitrant neovascular age-related macular degeneration
Conclusion:
Intravitreal high-dose high-frequency aflibercept is an effective treatment for patients with refractory wet age-related macular degeneration.
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Avastin | Eyes | Lucentis | Ranibizumab Injection | Study | Vitamin A